Zai Lab Announces Participation in September Investor Conferences
On August 23, 2022, Zai Lab Limited (NASDAQ: ZLAB) announced participation in several investor conferences in September.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
On August 23, 2022, Zai Lab Limited (NASDAQ: ZLAB) announced participation in several investor conferences in September. These include the 5th HKEX Biotech Summit on September 1, Citi’s 17th Annual BioPharma Conference on September 8, and others in New York. The events will feature presentations and panel discussions aimed at advancing their mission to provide transformative medicines. Zai Lab operates in oncology, autoimmune disorders, infectious diseases, and neurological disorders, focusing on improving global human health.
Positive
- Participation in multiple high-profile investor conferences enhances visibility and investor engagement.
- Focus on transformative medicines in critical health areas may attract positive market interest.
Negative
- None.
Details
News Market Reaction – ZLAB
The recorded move for ZLAB in the trading session of this news was +0.36%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced that management from Zai Lab will participate in the following investor conferences in September:
5th HKEX Biotech Summit 2022
Panel Discussion: Thursday, September 1, 2022, 3:10 p.m. HKT
Location: Hong Kong
Citi’s 17th Annual BioPharma Conference
Fireside Chat: Thursday, September 8, 2022, 8:50 a.m. ET
Location: Boston, MA
3rd Annual Jefferies Asia Forum
Presentation: Friday, September 9, 2022, 11:00 a.m. HKT
Morgan Stanley 20th Annual Global Healthcare Conference
Meetings: Wednesday, September 14, 2022
Location: New York
Cantor Oncology, Hematology & HemeOnc Conference
Meetings: Wednesday, September 28, 2022
Location: New York
Webcast links of the presentations will be available under “Events & Presentations” in the “Investor Relations” section of Zai Lab’s website. The archived replay will be viewable after the events for 90 days.
About Zai Lab
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States focused on bringing transformative medicines for oncology, autoimmune disorders, infectious diseases, and neurological disorders to patients in China and around the world. Our goal is to leverage our competencies and resources to positively impact human health worldwide.
For additional information about Zai Lab, including our products, business activities and partnerships, research, and other events or developments, please visit www.zailaboratory.com or follow us at www.twitter.com/ZaiLab_Global.
For more information, please contact:
Investor Relations: Lina Zhang
+86 136 8257 6943
lina.zhang@zailaboratory.com
Media: Danielle Halstrom / Xiaoyu Chen
+1 (215) 280-3898 / +86 185 0015 5011
danielle.halstrom@zailaboratory.com / xiaoyu.chen@zailaboratory.com
Zai Lab Limited
Source: Zai Lab Limited
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.